US Broker Ratings

Centene Corporation (CNC) Stock Analysis: Exploring a 20% Upside Potential

Centene Corporation (NYSE: CNC), a prominent player in the Healthcare Plans industry, has piqued investor interest with its potential upside of 20.09% based on current analyst..

Quest Diagnostics Incorporated (DGX)

⚠️ No article content returned.

..

Cencora, Inc. (COR) Stock Analysis: Healthcare Giant with 14% Upside Potential

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. With a..

ICON plc (ICLR) Stock Analysis: Exploring a 21.84% Potential Upside in the Healthcare Sector

ICON plc (ICLR), a leading player in the healthcare sector, particularly in diagnostics and research, is drawing significant attention from investors. Based in Dublin, Ireland, ICON..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A Promising 18.34% Upside for Investors

GE HealthCare Technologies Inc. (NYSE: GEHC) is a prominent player in the healthcare sector, specifically within the health information services industry. Headquartered in Chicago, Illinois, the..

The Cigna Group (CI) Stock Analysis: Evaluating a 22.27% Upside in the Healthcare Sector

The Cigna Group (NYSE: CI), a prominent player in the healthcare plans industry, presents a compelling opportunity for investors seeking exposure in the healthcare sector. With..

Intuitive Surgical, Inc. (ISRG): Investor Outlook Highlights 22.99% Potential Upside

Intuitive Surgical, Inc. (NASDAQ: ISRG) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a substantial market..

Insmed Incorporated (INSM) Stock Analysis: Riding High on Biotech Innovation with a 9% Upside Potential

Investors looking for opportunities in the biotechnology sector may find Insmed Incorporated (NASDAQ: INSM) a compelling choice. With a market capitalization of $28.77 billion, Insmed stands..

Exact Sciences Corporation (EXAS) Stock Analysis: Investors Eye a 32.79% Upside in the Booming Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is capturing investor attention with its potential..

Haleon plc (HLN) Stock Analysis: Unlocking an 18% Upside Potential in the Healthcare Sector

Haleon plc (HLN), a leading player in the healthcare sector, is capturing the attention of individual investors with its substantial market capitalization of $43.9 billion and..

argenx SE (ARGX) Stock Analysis: Strong Buy Ratings Signal Potential for Growth in the Biotech Sector

argenx SE (NASDAQ: ARGX), a prominent player in the biotechnology sector, is attracting significant attention from investors, driven by its robust pipeline and favorable market metrics...

Smith & Nephew SNATS, Inc. (SNN) Stock Report: Navigating Growth with Strategic Strength in Healthcare

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector with a focus on medical devices, represents a compelling investment opportunity despite..

BioNTech SE (BNTX) Investor Outlook: Analyzing a Potential 37.78% Upside in the Biotech Sector

BioNTech SE (NASDAQ: BNTX), a notable player in the biotechnology sector, has captured investor interest with its innovative approach to immunotherapies aimed at treating cancer and..

GSK plc (GSK) Stock Analysis: Navigating Opportunities in a Challenging Market Landscape

GSK plc (GSK), the British pharmaceutical powerhouse, is a prominent player in the healthcare sector, focusing on the development and manufacturing of vaccines and specialty medicines...

Genmab A/S (GMAB) Stock Analysis: Biotechnology’s Rising Star with a 22.89% Potential Upside

For investors with a keen eye on the biotechnology sector, Genmab A/S (NASDAQ: GMAB) presents an intriguing opportunity. Headquartered in Copenhagen, Denmark, Genmab specializes in developing..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring the 20% Upside Potential

Universal Health Services, Inc. (NYSE: UHS), a leader in the healthcare sector, operates a diverse portfolio of medical care facilities across the United States. With a..

Novartis AG (NVS) Stock Analysis: Revenue Growth Shines Amid Mixed Analyst Ratings

Investors have a keen interest in Novartis AG (NYSE: NVS), a Swiss healthcare giant with a robust market cap of $244.98 billion. Operating in the general..

Sanofi (SNY) Stock Analysis: A 25% Upside Potential in the Healthcare Giant

Sanofi (NASDAQ: SNY), a formidable player in the global healthcare industry, stands tall with a market capitalization of $121.19 billion. This French multinational, headquartered in Paris,..

Zoetis Inc. (ZTS) Investor Outlook: Unpacking a 21.67% Potential Upside Amid Robust Market Position

Zoetis Inc. (NYSE: ZTS), a leader in the animal health sector, presents an intriguing prospect for investors seeking solid growth potential in the healthcare industry. As..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Eyeing a 43.20% Upside with Innovative Biotech Advances

Summit Therapeutics Inc. (NASDAQ: SMMT) is drawing significant attention in the biotechnology sector, offering a potential upside of 43.20% according to recent analyst ratings. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds